Aymen Shatnawi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Clinical Decision Support

Top Venues

International journal of breast cancer

Journal of medical education and curricular development

Breast cancer : basic and clinical research

Molecular and cellular biochemistry

University of Charleston

University of Toledo Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Charleston Jan 01 2015

United States

Assistant professor :: pharmaceutical and administrative sciences

Education History

University of Toledo Medical Center Jan 01 2003 - Dec 23 2007

United States

PHD :: Biochemistry and cancer biology

Publications

Yazan R Alhamdan, Nehad M Ayoub, Sara K Jaradat, Aymen Shatnawi, Rami J Yaghan
BRAF Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer. International journal of breast cancer 2024 (2024)
Yazan R Alhamdan, Nehad M Ayoub, Sara K Jaradat, Aymen Shatnawi, Rami J Yaghan
BRAF Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer. International journal of breast cancer 2024 (2024)
Aymen Shatnawi, Nehad M Ayoub, Amer E Alkhalifa, Dalia R Ibrahim
Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer. Breast cancer : basic and clinical research 16 (2022)
Aymen Shatnawi, Zourayz Kamran, Qusai Al-Share
Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety. Personalized medicine (2022)
Dara Basyouni, Aymen Shatnawi
Pharmacogenomics Instruction Depth, Extent, and Perception in US Medical Curricula. Journal of medical education and curricular development 7 (2020)
Aymen Shatnawi, Sridhar A Malkaram, Tamer Fandy, Efrosini Tsouko
Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy. Molecular and cellular biochemistry 464 (1-2) (2019)